Table 3.
Indication | Non-Elective; n | Elective CS; n | Total CS; n | Total CS; % |
---|---|---|---|---|
Fetal distress | 470 | 5 | 475 | 22.8% |
Malpresentation | 442 | 10 | 452 | 21.7% |
Failed induction | 378 | 8 | 386 | 18.5% |
Dynamic dystocia | 50 | 4 | 54 | 2.6% |
Pelvic anomalies | 27 | 116 | 143 | 6.9% |
Maternal anxiety | 10 | 20 | 30 | 1.4% |
Cephalopelvic disproportion | 17 | 28 | 45 | 2.2% |
Fetal growth restriction | 15 | 23 | 38 | 1.8% |
Hypertension or preeclampsia | 23 | 13 | 36 | 1.7% |
Placental abruption | 20 | 0 | 20 | 1.0% |
Elderly primigravida | 1 | 17 | 18 | 0.9% |
Placenta praevia | 4 | 19 | 23 | 1.1% |
Macrosomia | 2 | 6 | 8 | 0.4% |
Gestational diabetes mellitus | 6 | 9 | 15 | 0.7% |
Oligohydramnios | 8 | 13 | 21 | 1.0% |
Maternal fever | 7 | 0 | 7 | 0.3% |
Umbilical cord prolapse | 5 | 0 | 5 | 0.2% |
Polyhydramnios | 1 | 10 | 11 | 0.5% |
Operative vaginal delivery | 5 | 0 | 5 | 0.2% |
Prolonged pregnancy | 5 | 4 | 9 | 0.4% |
Other maternal pathology | 6 | 19 | 25 | 1.2% |
Fetal pathology | 11 | 6 | 17 | 0.8% |
Others | 95 | 148 | 243 | 11.7% |
Total | 1,608 | 478 | 2,086 | 100.0% |